MWNA
BLU

Marshall Wace North America’s BELLUS Health Inc. BLU Stock Holding History

Marshall Wace North America’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$7.67M Buy
1,248,861
+63,652
+5% +$241K 0.03% 407
2021
Q2 		$3.69M Hold
1,185,209
– – 0.02% 641
2021
Q1 		$4.55M Hold
1,185,209
– – 0.02% 597
2020
Q4 		$3.63M Buy
1,185,209
+562,500
+90% +$1.52M 0.02% 607
2020
Q3 		$1.41M Sell
622,709
-867,782
-58% -$2.46M 0.01% 701
2020
Q2 		$15.3M Buy
1,490,491
+955,059
+178% +$9.68M 0.1% 209
2020
Q1 		$5.34M Buy
+535,432
New +$4.77M 0.04% 307

Other funds holding BLU

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Marshall Wace North America's BLU Position: Q3 2021 in Review

Marshall Wace North America increased its BELLUS Health Inc. (BLU) stake by 5.4% in Q3 2021, buying an estimated $241K and bringing the position to 1,248,861 shares worth $7.67M. The position accounts for 0.03% of the portfolio, ranked #407.

Marshall Wace North America first reported a position in BLU in Q1 2020 and has held it in 7 quarters since. The position peaked at $15.3M in Q2 2020. 56 funds tracked by Wall St. Rank hold BLU as of Q3 2021.

  • Marshall Wace North America held 1,248,861 shares of BELLUS Health Inc. worth $7.67M as of Q3 2021.
  • Marshall Wace North America bought 63,652 BELLUS Health Inc. shares in Q3 2021, an estimated $241K.
  • BELLUS Health Inc. made up 0.03% of Marshall Wace North America's portfolio in Q3 2021, its #407 holding.
  • Marshall Wace North America first reported a position in BELLUS Health Inc. in Q1 2020 and has held it in 7 quarters since.
  • Marshall Wace North America's BELLUS Health Inc. position peaked at $15.3M in Q2 2020.
  • 56 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.